One Ascent Wealth Management LLC Argenx Se Transaction History

One Ascent Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	SELL	$369.35 - $548.43 $37,304 - $55,391	-101 Reduced 18.67%	440 $216,000
Q2 2023 Jul 10, 2023	SELL	$360.14 - $422.58 $2,520 - $2,958	-7 Reduced 1.28%	541 $211,000
Q1 2023 Apr 17, 2023	BUY	$334.23 - $403.65 $183,158 - $221,200	548 New	548 $204,000
Q2 2022 Aug 08, 2022	SELL	$269.58 - $378.88 $33,967 - $47,738	-126 Reduced 13.25%	825 $313,000
Q1 2022 May 12, 2022	BUY	$254.45 - $351.06 $241,981 - $333,858	951 New	951 $300,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of One Ascent Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Wealth Management LLC with notifications on news.